Status:
COMPLETED
Efficacy and Safety of Different Doses of Vaginal Misoprostol Prior to Intra Uterine Contraceptive Device Insertion
Lead Sponsor:
Ain Shams University
Conditions:
Intra-uterine Device Complication
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
investigators aim through this study to evaluate and compare the Safety and efficacy of different doses of misoprostol prior to IUCD insertion among women with nulliparous cervix beside the rate of oc...
Detailed Description
Today there is an ever-increasing variety of effective contraceptive methods. Although all have side effects, they offer a lower risk than that conferred by pregnancy Contraceptive methods are classif...
Eligibility Criteria
Inclusion
- Non-pregnant,
- Nulliparous cervix: no previous vaginal delivery or any attempt of vaginal delivery,
- Seeking for IUD insertion,
- Signing an informed consent to participate in the study,
Exclusion
- Pregnancy or signs of pregnancy,
- Signs of cervicitis,
- Any uterine abnormalities as congenital anomalies, endometrial lesions, adenomyosis, fibroids and intrauterine adhesions,
- Women with any kind of pelvic pain,
- Abnormal uterine bleeding,
- History of cervical surgery,• Vaginal delivery,
- Contraindication to misoprostol as allergy,
- Administration of any analgesics last 12h,
- Withdrawal of consent
Key Trial Info
Start Date :
March 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT04273984
Start Date
March 1 2020
End Date
June 30 2020
Last Update
July 14 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University Maternity Hospital
Cairo, Egypt
2
Misr University for Science & Technology
Cairo, Egypt